• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Unregistered Unregistered  酒井 遥

ORCIDConnect your ORCID iD *help
… Alternative Names

SAKAI Haruka  酒井 遥

Less
Researcher Number 80757609
Affiliation (Current) 2025: 関西医科大学, 医学部, 研究員
Affiliation (based on the past Project Information) *help 2020 – 2022: 関西医科大学, 医学部, 研究員
Review Section/Research Field
Principal Investigator
Basic Section 56050:Otorhinolaryngology-related
Keywords
Principal Investigator
放射性ヨウ素内用療法 / 分子標的薬併用放射線療法 / 放射線療法 / 併用療法 / レンバチニブ / 分子標的薬 / I-131 / 外照射 / 甲状腺癌
  • Research Projects

    (1 results)
  • Research Products

    (5 results)
  • Co-Researchers

    (1 People)
  •  Development of combination therapy with molecular targeted drugs and internal/external radiation therapy for thyroid cancerPrincipal Investigator

    • Principal Investigator
      SAKAI Haruka
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56050:Otorhinolaryngology-related
    • Research Institution
      Kansai Medical University

All 2022 2021

All Journal Article Presentation

  • [Journal Article] レンバチニブ併用放射線療法を用いた甲状腺癌治療に向けての基礎研究2022

    • Author(s)
      鈴木 健介, 岩井 大, 宇都宮 啓太, 河野 由美子, 小林 良樹, Dan Van Bui, 澤田 俊輔, 尹 泰貴, 三谷 彰俊, 福井 研太, 酒井 遥, 谷川 昇, 神田 晃
    • Journal Title

      耳鼻咽喉科ニューロサイエンス

      Volume: 35 Pages: 73-75

    • Data Source
      KAKENHI-PROJECT-20K18269
  • [Journal Article] Potential of combination therapy with lenvatinib and radiation for thyroid cancer2022

    • Author(s)
      鈴木 健介,岩井 大,宇都宮 啓太,河野 由美子,小林 良樹,尹 泰貴, 三谷 彰俊,福井 研太,酒井 遥,谷川 昇,神田 晃
    • Journal Title

      The Journal of Kansai Medical University

      Volume: 73 Issue: 0 Pages: 1-5

    • DOI

      10.5361/jkmu.73.1

    • ISSN
      0022-8400, 2185-3851
    • Language
      Japanese
    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K16921, KAKENHI-PROJECT-20K18269, KAKENHI-PROJECT-20K18297
  • [Journal Article] Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model2022

    • Author(s)
      Kensuke Suzuki, Hiroshi Iwai, Keita Utsunomiya, Yumiko Kono, Tadashi Watabe, Yoshiki Kobayashi, Dan Van Bui, Shunsuke Sawada, Yasutaka Yun, Akitoshi Mitani, Kenta Fukui, Haruka Sakai, Hanh Hong Chu, Nguyen Manh Linh, Noboru Tanigawa and Akira Kanda
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 23(17) Issue: 17 Pages: 9872-9872

    • DOI

      10.3390/ijms23179872

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K16921, KAKENHI-PROJECT-20K18269, KAKENHI-PROJECT-20K18297
  • [Presentation] 基礎研究からみた甲状腺癌に対するレンバチニブ併用放射線療法の可能性2021

    • Author(s)
      鈴木 健介,岩井 大,宇都宮 啓太,河野 由美子,三谷 彰俊,酒井 遥,福井 研太,谷川 昇
    • Organizer
      第57回日本医学放射線学会秋季臨床学会(シンポジウム)
    • Invited
    • Data Source
      KAKENHI-PROJECT-20K18269
  • [Presentation] レンバチニブ併用放射線療法を用いた甲状腺癌治療に向けての基礎研究2021

    • Author(s)
      鈴木 健介,岩井 大,宇都宮 啓太,河野 由美子,小林 良樹,Dan Van Bui,澤田 俊輔,尹 泰貴,三谷 彰俊,福井 研太,酒井 遥,谷川 昇,神田 晃
    • Organizer
      第38回耳鼻咽喉科ニューロサイエンス研究会
    • Data Source
      KAKENHI-PROJECT-20K18269
  • 1.  鈴木 健介
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi